Immunotherapy for canine osteosarcoma yields promising findings

11/18/2013 | Bark online, The

Veterinarian Nicola Mason of the University of Pennsylvania School of Veterinary Medicine has been working on a vaccine to treat canine osteosarcoma, an aggressive cancer that attacks the bones of large-breed dogs. Treatment typically involves amputation with or without chemotherapy. The vaccine uses bacteria that have been modified to express a growth factor receptor common to cancer cells, stimulating the dogs' own immune systems to attack tumor cells. Dr. Mason has treated 12 dogs, and preliminary results have been encouraging, with several dogs cancer-free more than 500 days after diagnosis.

View Full Article in:

Bark online, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX